Delivery Order SPE2DB25D3306-SPE2DB25FUBMS
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,097.44 delivery order to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price. The award was executed on June 2, 2025, with an ultimate completion date of June 3, 2025, and performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,062.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trumenba 120 MCG/0.5 ML vaccine on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as the performance site for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $2,125.04 delivery order to AmerisourceBergen Drug Corp for Trumenba 120 MCG/0.5 ML vaccine on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract is classified as a delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,872.68 to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. This non-set-aside, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a procurement of pharmaceutical products supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.52 to AmerisourceBergen Drug Corp for the supply of Trumenba (meningococcal vaccine B) 120 mcg/0.5 mL doses on August 14, 2025, with completion targeted for August 15, 2025. The order represents a firm fixed price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of 120 mcg/0.5 ml doses of the TRUMENBA vaccine, a total ceiling value of $2,125.04. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $1,062.52 and is a Firm Fixed Price type contract. The place of performance is Conshohocken, Pennsylvania. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The firm-fixed-price contract, valued at $4,950.60, has a performance period through May 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBMSDelivery Order
This delivery order, valued at $1,264.96, was awarded to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trumenba 120 MCG/0.5 ML vaccine in 0.5 ML quantities. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), with performance to be completed by April 25, 2025, and fulfillment at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was competitively awarded. This award is a child delivery order executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor specializing in federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply vaccines, medications, and medical supplies to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated sustained capability in managing firm fixed-price delivery orders across diverse pharmaceutical product categories in support of military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/25 |